Eliminate manual errors, accelerate regulatory approvals, and stay compliant with an AI-powered eCTD submission platform that automates document processing and validation.
About Us
At NuMantra Technologies, we’re building the next-generation AI-powered eCTD submission automation platform—designed to eliminate inefficiencies in regulatory workflows for pharmaceutical and life sciences companies. While our product is currently in development, we’re actively collaborating with industry professionals to ensure it meets real-world compliance needs. We’re looking for industry partners to help shape our intelligent document processing (IDP) and generative AI solutions—automating submission validation, document structuring, and compliance tracking. Join us in revolutionizing regulatory submissions with AI-driven efficiency. Let’s build the future of eCTD together.
Regulatory submissions are complex, time-consuming, and prone to human errors. Teams spend weeks formatting, validating, and compiling eCTD dossiers—leading to costly delays and compliance risks.
Our AI-driven platform aims to simplify eCTD submission preparation with:
Step 01
Drag & drop or integrate with your existing systems.
Step 02
Our AI formats, validates, and compiles submission-ready eCTD files.
Step 03
Identify and correct compliance risks before submission.
Step 04
One-click eCTD submission with a complete audit trail.
Avoid rejections with automated validation.
Automate tedious tasks and free up your team.
Stay compliant with evolving global regulations.
Connect with your existing document management systems.
Are you a regulatory affairs professional, compliance officer, or CRO manager struggling with time-consuming eCTD submissions? NuMantra Technologies is developing an AI-powered automation platform to streamline submission validation, document structuring, and compliance tracking.
We’re looking for industry partners to collaborate with us and provide real-world insights to ensure our solution meets industry needs. As a beta partner, you’ll gain early access to our platform, provide feedback on key features, and help shape the next generation of regulatory automation.